These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27657044)

  • 1. Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.
    León-Mateos L; Vieito M; Anido U; López López R; Muinelo Romay L
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27657044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour cells: their utility in cancer management and predicting outcomes.
    Krebs MG; Hou JM; Ward TH; Blackhall FH; Dive C
    Ther Adv Med Oncol; 2010 Nov; 2(6):351-65. PubMed ID: 21789147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.
    Lorente D; Olmos D; Mateo J; Dolling D; Bianchini D; Seed G; Flohr P; Crespo M; Figueiredo I; Miranda S; Scher HI; Terstappen LWMM; de Bono JS
    Ann Oncol; 2018 Jul; 29(7):1554-1560. PubMed ID: 29741566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells: from bench to bedside.
    Balic M; Williams A; Lin H; Datar R; Cote RJ
    Annu Rev Med; 2013; 64():31-44. PubMed ID: 23092385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.
    Mohan S; Chemi F; Brady G
    Transl Lung Cancer Res; 2017 Aug; 6(4):454-472. PubMed ID: 28904889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
    O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
    Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer.
    Davies CR; Guo T; Burke E; Stankiewicz E; Xu L; Mao X; Scandura G; Rajan P; Tipples K; Alifrangis C; Wimalasingham AG; Galazi M; Crusz S; Powles T; Grey A; Oliver T; Kudahetti S; Shaw G; Berney D; Shamash J; Lu YJ
    Front Oncol; 2022; 12():1060864. PubMed ID: 36727071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models.
    Hassan S; Blick T; Thompson EW; Williams ED
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34206049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and clinical significance of circulating tumour cells in patients with colorectal carcinoma.
    Ihnát P; Srovnal J; Hrubovčák J; Martínek L
    Rozhl Chir; 2023; 102(10):376-380. PubMed ID: 38302423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer.
    Belderbos BPS; Sieuwerts AM; Hoop EO; Mostert B; Kraan J; Hamberg P; Van MN; Beaufort CM; Onstenk W; van Soest RJ; Martens J; Sleijfer S; de Wit R; Mathijssen RHJ; Lolkema MP
    Eur J Cancer; 2019 Nov; 121():48-54. PubMed ID: 31542641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models.
    Hassan S; Blick T; Wood J; Thompson EW; Williams ED
    Front Cell Dev Biol; 2022; 10():858013. PubMed ID: 35493092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumour cells in metastatic head and neck cancers.
    Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
    Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling circulating tumour cells and other biomarkers of invasive cancers.
    Poudineh M; Sargent EH; Pantel K; Kelley SO
    Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTC-5: A novel digital pathology approach to characterise circulating tumour cell biodiversity.
    Ffrench B; Kashdan E; Huang Y; Spillane CD; Cocchiglia S; Charmsaz S; Varešlija D; O'Brien C; Scholz D; Martin C; Gallagher M; Brooks DA; Brooks RD; Selemidis S; Gleeson N; AbuSaadeh F; O'Riain C; Kamran W; Flavin R; Young L; O'Toole SA; O'Leary JJ
    Heliyon; 2023 Jan; 9(1):e13044. PubMed ID: 36747925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy.
    Chauhan A; Kaur R; Ghoshal S; Pal A
    Indian J Clin Biochem; 2021 Apr; 36(2):131-142. PubMed ID: 33867703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Progress for the Clinical Application of Circulating Tumor Cells in Prostate Cancer Diagnosis and Treatment.
    Yang M; Zhang X; Guo L; Liu X; Wu J; Zhu H
    Biomed Res Int; 2021; 2021():6230826. PubMed ID: 33506020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and clinical utility of prostate cancer biomarkers.
    Scher HI; Morris MJ; Larson S; Heller G
    Nat Rev Clin Oncol; 2013 Apr; 10(4):225-34. PubMed ID: 23459624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
    Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
    N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of rare circulating tumour cells in cancer patients by microchip technology.
    Nagrath S; Sequist LV; Maheswaran S; Bell DW; Irimia D; Ulkus L; Smith MR; Kwak EL; Digumarthy S; Muzikansky A; Ryan P; Balis UJ; Tompkins RG; Haber DA; Toner M
    Nature; 2007 Dec; 450(7173):1235-9. PubMed ID: 18097410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.